Rifampicin in experimental Mycobacterium ulcerans infection.
D000818:Animals; D004338:Drug Combinations; D005528:Foot; D006614:Hindlimb; D008297:Male; D051379:Mice; D009164:Mycobacterium Infections / Q000188:drug therapy*; D010619:Phenazines / Q000008:administration & dosage / Q000627:therapeutic use; D011739:Pyrimethamine / Q000008:administration & dosage / Q000627:therapeutic use; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*; D012883:Skin Ulcer / Q000188:drug therapy*; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use
D004338:Drug Combinations; D010619:Phenazines; D011743:Pyrimidines; D013449:Sulfonamides; D012293:Rifampin; D011739:Pyrimethamine